In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

The Dow Jones Industrial Average climbed on Thursday (July 10) as investors brushed aside concerns over new tariff ...

Chemical maker DuPont has agreed to a $27 million settlement to resolve a nearly decade-long lawsuit over the contamination of an upstate New York village’s water supply ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Attorney General Dave Sunday announced that Pennsylvania is part of an approximately $720 million combined national ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.

GSK, its consumer health spin-off Haleon, and Sanofi could be on the hook for billions of dollars in potential damages over Zantac, a gastrointestinal drug pulled from the market in 2020 after it ...

Attorney General Dave Sunday announced this week that Pennsylvania is part of an approximately $720 million combined national settlement with eight drug manufacturers that worsened the nationwide ...